Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing ledipasvir and sofosbuvir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ledipasvir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ledipasvir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ledipasvir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ledipasvir and sofosbuvir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ledipasvir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet |
Has precise active ingredient |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet |
Has precise active ingredient |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet |
Has basis of strength substance (attribute) |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) |
Has precise active ingredient |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ledipasvir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |